Cite
APA Citation
Baalbaki, N., Blum, S., Bosco, M., Akerman, M., Zaki, L., & Johnson, D. (n.d.). 1259. Carbapenems Versus Non-carbapenem Beta-Lactams for the Treatment of Ceftriaxone-Susceptible and Piperacillin-Tazobactam-Nonsusceptible Enterobacterales Isolates. Open forum infectious diseases, 8, S718. http://access.bl.uk/ark:/81055/vdc_100150542156.0x00002b